RECRUITING

Ketamine Assisted Psychotherapy for Opioid Use Disorder

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This pilot clinical trial aims to assess the preliminary efficacy of ketamine as an adjunct for a mindfulness-based intervention for opioid use disorder.

Official Title

Ketamine Assisted Psychotherapy for Opioid Use Disorder

Quick Facts

Study Start:2021-05-20
Study Completion:2024-05-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04892251

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Diagnosis of Opioid Use Disorder
  2. 2. Receiving OUD treatment with a buprenorphine formulation
  1. 1. Previous experience with a mindfulness-based intervention program
  2. 2. Pregnancy
  3. 3. Any serious medical, mental, or cognitive issue that prevents successful participation in a mindfulness-based group treatment program
  4. 4. Prior use of ketamine other than as prescribed by a physician
  5. 5. Any of the following medical conditions

Contacts and Locations

Study Contact

Research Coordinator
CONTACT
801-581-3826
eric.garland@socwk.utah.edu

Principal Investigator

Eric L Garland
PRINCIPAL_INVESTIGATOR
University of Utah

Study Locations (Sites)

Center on Mindfulness and Integrative Health Intervention Development
Salt Lake City, Utah, 84112
United States

Collaborators and Investigators

Sponsor: University of Utah

  • Eric L Garland, PRINCIPAL_INVESTIGATOR, University of Utah

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-05-20
Study Completion Date2024-05-30

Study Record Updates

Study Start Date2021-05-20
Study Completion Date2024-05-30

Terms related to this study

Additional Relevant MeSH Terms

  • Opioid-use Disorder